Իսրայել - եբրայերեն - Ministry of Health

teva pharmaceutical indust.ltd - naproxen 250 mg - tablets - naproxen - - relief of the signs and symptoms of rheumatic diseases including osteoarthritis, ankylosing spondylitis of rheumatoid arthritis, both in the treatment of acute flares and in the long-term management of the disease. - juvenile rheumatoid arthritis. - periarticular and musculoskeletal disorders.- relief of pain in bursitis, tendinitis, synovitis, tenosynovitis and lumbago. - relief of pain, swelling, tenderness and fever in acute gouty arthritis. - relief of symptoms of primary dysmenorrhea.

Իսրայել - եբրայերեն - Ministry of Health

teva pharmaceutical indust.ltd - pergolide as mesylate 0.25 mg - tablets - pergolide - pergolide is indicated as adjunctive treatment to levodopa/carbidopa in the management of the signs and symptoms of parkinson's disease with on-off phenomena. pergolide is indicated as monotherapy in the initial treatment period of parkinson's disease.

Իսրայել - եբրայերեն - Ministry of Health

sigma-aldrich israel - כלל האוכלוסיה - חומרי אבטחת איכות למעבדות

Իսրայել - եբրայերեն - Ministry of Health

padagis israel pharmaceuticals ltd, israel - lactulose - סירופ - lactulose 66.7 g / 100 ml - lactulose - lactulose - constipation. acute and chronic hepatic encephalopathy.

Իսրայել - եբրայերեն - Ministry of Health

trima israel pharmaceutical products maabarot ltd - nabumetone - טבליה - nabumetone 500 mg - nabumetone - nabumetone - acute and chronic treatment of the signs and symptoms of osteoarthritis and rheumatoid arthritis and similar conditions requiring anti-inflamatory treatment.

Իսրայել - եբրայերեն - Ministry of Health

trima israel pharmaceutical products maabarot ltd - pramipexole dihydrochloride monohydrate 0.25 mg - tablets - pramipexole - treatment of signs and symptoms of idiopathic parkinson's disease, as monotherapy or in combination with levodopa. for symptomatic treatment of moderate to severe idiopathic restless legs syndrome.

Իսրայել - եբրայերեն - Ministry of Health

trima israel pharmaceutical products maabarot ltd - pramipexole dihydrochloride monohydrate 1 mg - tablets - pramipexole - treatment of signs and symptoms of idiopathic parkinson's disease, as monotherapy or in combination with lovodopa.

Իսրայել - եբրայերեն - Ministry of Health

abbvie biopharmaceuticals ltd, israel - botulinum toxin type a - אבקה להכנת תמיסה לזריקה - botulinum toxin type a 100 u/vial - botulinum toxin - botulinum toxin - botox is indicated for the symptomatic relief of blepharospasm or vii nerve disorders in patients over 12 years hemifacial spasm and associated focal dystonias as well as the correction of strabismus in patients 12 years of age and above. botox is also indicated for the reduction of the signs and symptoms of spasmodic torticollis ( cervical dystonia) in adults. botox is also indicated for the treatment of dynamic equinus foot deformity due to spasticity in paediatric cerebral palsy patients two years of age or older. focal upper limb spasticity associated with stroke. botox is indicated also for the temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity in adult patients aged 65 years or less. management of primary axillary hyperhidrosis in patients who failed other medical symptomatic treatment.symptom relief in adults fulfilling criteria for chronic migraine (headaches on ?15 days per month of which at least 8 days with migrai

Իսրայել - եբրայերեն - Ministry of Health

abbvie biopharmaceuticals ltd, israel - botulinum toxin type a - אבקה להכנת תמיסה לזריקה - botulinum toxin type a 50 u/vial - botulinum toxin - botulinum toxin - botox is indicated for the symptomatic relief of blepharospasm or vii nerve disorders in patients over 12 years hemifacial spasm and associated focal dystonias as well as the correction of strabismus in patients 12 years of age and above. botox is also indicated for the reduction of the signs and symptoms of spasmodic torticollis ( cervical dystonia) in adults. botox is also indicated for the treatment of dynamic equinus foot deformity due to spasticity in paediatric cerebral palsy patients two years of age or older. focal upper limb spasticity associated with stroke. botox is indicated also for the temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity in adult patients aged 65 years or less. management of primary axillary hyperhidrosis in patients who failed other medical symptomatic treatment.symptom relief in adults fulfilling criteria for chronic migraine (headaches on ?15 days per month of which at least 8 days with migrai

Իսրայել - եբրայերեն - Ministry of Health

abbvie biopharmaceuticals ltd, israel - botulinum toxin type a - אבקה להכנת תמיסה לזריקה - botulinum toxin type a 200 u/vial - botulinum toxin - botulinum toxin - botox is indicated for the symptomatic relief of blepharospasm or vii nerve disorders in patients over 12 years hemifacial spasm and associated focal dystonias as well as the correction of strabismus in patients 12 years of age and above. botox is also indicated for the reduction of the signs and symptoms of spasmodic torticollis ( cervical dystonia) in adults. botox is also indicated for the treatment of dynamic equinus foot deformity due to spasticity in paediatric cerebral palsy patients two years of age or older. focal upper limb spasticity associated with stroke. botox is indicated also for the temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity in adult patients aged 65 years or less.management of primary axillary hyperhidrosis in patients who failed other medical symptomatic treatment.symptom relief in adults fulfilling criteria for chronic migraine (headaches on ?15 days per month of which at least 8 days with migrain